Patient Characteristics | Inpatient (n = 25) | Outpatient (n = 53) | Total (total n = 78) |
---|---|---|---|
Age | |||
Mean (SD) | 48.1 (21.2) | 47.8 (17.6) | 47.7 (18.5) |
Median (IQR) | 40 (34.5) | 43 (32) | 41 (32.3) |
Gender | |||
Male | 13 (52%) | 33 (62%) | 46 (59%) |
Female | 12 (48%) | 20 (38%) | 32 (41%) |
Wells Score: | |||
Unlikely | 2 (8%) | 6 (11%) | 8 (10%) |
Likely | 10 (40%) | 24 (45%) | 34 (44%) |
Not assessed | 13 (52%) | 23 (44%) | 36 (46%) |
D-dimer: | |||
Raised | 12 (48%) | 31 (58%) | 43 (55%) |
Normal Range | 0 (0%) | 2 (4%) | 2 (3%) |
Not measured | 13 (52%) | 20 (38%) | 33 (42%) |
History of VTE | 9 (36%) | 19 (36%) | 28 (36%) |
Provoking factor | 17 (68%) | 32 (60%) | 49 (63%) |
Associated PE | 12 (48%) | 3 (5%) | 15 (19%) |
Location: | |||
Upper limb | 1 (4%) | 1 (2%) | 2 (3%) |
Lower limb | 24 (96%) | 52 (98%) | 76 (97%) |
Treatment: | |||
Rivaroxaban | 4 (16%) | 31 (58%) | 35 (45%) |
LMWH | 18 (72%) | 22 (42%) | 40 (51%) |
Not recorded | 3 (12%) | 0 (0%) | 3 (4%) |
Medical Comorbidities | 5 (25%) | 17 (32%) | 23 (55%) |
IVDU | 10 (40%) | 21 (42%) | 31 (39%) |
Bleeding Complications | 1 (4%) | 5 (9%) | 6 (8%) |
Not recorded | 23 (92%) | 29 (54%) | 52 (66%) |
Post Partum | 1 (4%) | 2 (4%) | 3 (4%) |